ISG15 and breast carcinoma: As Desai et al. pointed out, reports of constitutive ISG15 expression in other cancer cell lines suggest that the effects of ISG15-mediated ISGylation on the cytoskeleton architecture in breast cancer cells [24] might also be associated with tumorigenesis in cancers originating from other tissue types.